Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
20,324 results
- Investigational Multi-purpose Contact Lens Care Solution.: Complete Statistical AnalysisIndependent statistical analysis of Investigational Multi-purpose Contact Lens Care Solution.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01055613).
- Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment: Complete Statistical AnalysisIndependent statistical analysis of Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Investigational Therapeutics for the Treatment of People With Ebola Virus Disease: Complete Statistical AnalysisIndependent statistical analysis of Investigational Therapeutics for the Treatment of People With Ebola Virus Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.: Complete Statistical AnalysisIndependent statistical analysis of Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01574157).
- INVICTAN®-3Independent statistical analysis of Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- INVIGORATEIndependent statistical analysis of Exacerbation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00845728).
- Involving Family to Improve Communication in Breast Cancer Care: Complete Statistical AnalysisIndependent statistical analysis of Involving Family to Improve Communication in Breast Cancer Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03283553).
- INVSENSOR00013 Respiratory Rate Clinical Performance Study: Complete Statistical AnalysisIndependent statistical analysis of INVSENSOR00013 Respiratory Rate Clinical Performance Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03440619).
- INVSENSOR00027 Clinical Performance Study: Complete Statistical AnalysisIndependent statistical analysis of INVSENSOR00027 Clinical Performance Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03650192).
- IO Vancomycin in TSA: Complete Statistical AnalysisIndependent statistical analysis of IO Vancomycin in TSA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05831774).
- IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC: Complete Statistical AnalysisIndependent statistical analysis of IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Iodine I 131 in Treating Patients With Thyroid Cancer: Complete Statistical AnalysisIndependent statistical analysis of Iodine I 131 in Treating Patients With Thyroid Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00416949).
- Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis: Complete Statistical AnalysisIndependent statistical analysis of Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ION-2Independent statistical analysis of Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ION-ASDIndependent statistical analysis of Oxytocin and Social Cognitive Skills Groups: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02918864).
- IONMIndependent statistical analysis of Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00191282).
- Iontophoresis With Dexamethasone and Physical Therapy to Treat Apophysitis of the Knee in Pediatrics: Complete Statistical AnalysisIndependent statistical analysis of Iontophoresis With Dexamethasone and Physical Therapy to Treat Apophysitis of the Knee in Pediatrics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IOOVIndependent statistical analysis of The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- IOOZIndependent statistical analysis of Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- IOPIndependent statistical analysis of Intraoperative Ocular Pressure in Lumbar Spine Fusion Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02342288).
- IOPAIndependent statistical analysis of A Study for Patients With Diabetes Mellitus (IOPA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00420095).
- Iota-Carrageenan Nasal Spray in Common Cold: Complete Statistical AnalysisIndependent statistical analysis of Iota-Carrageenan Nasal Spray in Common Cold: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01944631).
- IOVLIndependent statistical analysis of Intraoperative Video Laryngoscopy as Adjunct for Nerve Monitoring: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03742141).
- IPACIndependent statistical analysis of Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy: primary endpoint…
- iPACK for Post-op Pain Following ACL Reconstruction: Complete Statistical AnalysisIndependent statistical analysis of iPACK for Post-op Pain Following ACL Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05498870).
- IPATunity130Independent statistical analysis of A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer:…
- IPCIndependent statistical analysis of Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- IPCDIndependent statistical analysis of Impact of Pharmaceutical Care in Diabetics Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01580904).
- IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02803580).
- IPF-201Independent statistical analysis of Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox: Complete Statistical AnalysisIndependent statistical analysis of Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Ipilimumab and Local Radiation for Selected Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Ipilimumab and Local Radiation for Selected Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01769222).
- IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD: Complete Statistical AnalysisIndependent statistical analysis of IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IPOD-AVIndependent statistical analysis of Assessing the Incidence of Postoperative Delirium Following Aortic Valve Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03950440).
- iPOP-UPIndependent statistical analysis of Dissemination and Implementation of Improving Pediatric Obesity Practice Using Prompts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05627011).
- IPSSARIndependent statistical analysis of A Public Health Intervention Program to Improve the Initial Management of Soft Tissue Sarcomas.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults: Complete Statistical AnalysisIndependent statistical analysis of IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IQSIndependent statistical analysis of Improving Quitline Support Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03538938).
- iQuit Mindfully: Text Messaging for Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of iQuit Mindfully: Text Messaging for Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03029819).
- IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?: Complete Statistical AnalysisIndependent statistical analysis of IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IRC002Independent statistical analysis of Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma: primary endpoint results, effect estimate…
- Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery: primary endpoint results,…
- Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction: primary endpoint results, effect estimate with confidence interval,…
- Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- IRISIndependent statistical analysis of Exercise and Inflammation in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00753363).
- IRISIndependent statistical analysis of Influenza Resistance Information Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00884117).
- IRM-seinIndependent statistical analysis of Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…